Cargando…

622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)

BACKGROUND: Vancomycin-resistant enterococci (VRE) are a major cause of nosocomial bloodstream infections. Enterococci exhibit remarkable genomic plasticity and can recombine through the acquisition of genetic material via mobile genetic elements (MGEs), including resistance genes. The accessory gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Simar, Shelby, Hanson, Blake, Contreras, German, Reyes, Katherine, Sahasrabhojane, Pranoti V, Misikir, Helina, Liu, Catherine, Doi, Yohei, Barberis, Fernanda, Abbo, Lilian, Dinh, An Q, Spencer, Maria, Zervos, Marcus, Aitken, Samuel L, van Duin, David, Shelburne, Samuel A, Tran, Truc T, Munita, Jose M, Arias, Cesar A, de los Angeles Spencer, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811187/
http://dx.doi.org/10.1093/ofid/ofz360.690
_version_ 1783462420150222848
author Simar, Shelby
Hanson, Blake
Contreras, German
Reyes, Katherine
Sahasrabhojane, Pranoti V
Misikir, Helina
Liu, Catherine
Doi, Yohei
Barberis, Fernanda
Abbo, Lilian
Dinh, An Q
Spencer, Maria
Zervos, Marcus
Aitken, Samuel L
Aitken, Samuel L
van Duin, David
Shelburne, Samuel A
Shelburne, Samuel A
Tran, Truc T
Munita, Jose M
Arias, Cesar A
de los Angeles Spencer, Maria
author_facet Simar, Shelby
Hanson, Blake
Contreras, German
Reyes, Katherine
Sahasrabhojane, Pranoti V
Misikir, Helina
Liu, Catherine
Doi, Yohei
Barberis, Fernanda
Abbo, Lilian
Dinh, An Q
Spencer, Maria
Zervos, Marcus
Aitken, Samuel L
Aitken, Samuel L
van Duin, David
Shelburne, Samuel A
Shelburne, Samuel A
Tran, Truc T
Munita, Jose M
Arias, Cesar A
de los Angeles Spencer, Maria
author_sort Simar, Shelby
collection PubMed
description BACKGROUND: Vancomycin-resistant enterococci (VRE) are a major cause of nosocomial bloodstream infections. Enterococci exhibit remarkable genomic plasticity and can recombine through the acquisition of genetic material via mobile genetic elements (MGEs), including resistance genes. The accessory genome plays a major role in the evolution of enterococci within the human host. Thus, dissecting the entire genome (pan-genome) is of paramount importance to characterize the population structure of enterococci causing disease. METHODS: VENOUS is an ongoing prospective, observational study of adults with enterococcal bacteremia. From September 2016 to March 2018, E. faecalis (Efs) and E. faecium (Efm) were collected in 14 hospitals of a single hospital system and a major cancer center in Houston, TX, and a general hospital in Detroit, MI. Short- and long-read genomic sequencing were performed with Illumina MiSeq and Oxford Nanopore Technologies GridION X5, respectively. A proprietary bioinformatics pipeline was utilized for genome assembly and further analyses. RESULTS: 156 Efs and 98 Efm isolates from single patients were analyzed. The average proportion of core genes in each genome was 64.6% (53.0–74.1) and 49.1% (45.2–51.0) for Efs and Efm, respectively. The vanA gene cluster was identified in 5.1% (8/157) of Efs and 57.1% (56/98) of Efm. The plasmid-encoded aac(6′)-Ie-aph(2″)-Ia gene conferring high-level resistance to aminoglycosides was found in 37.6% (59/157) Efs, seven of which also possessed vanA. Long-read sequencing of vanA-harboring plasmids from a subset of VRE revealed that the vanA cluster was carried in plasmids ranging from 31.7 to 132.3 kb. Although the vanA operon was fairly conserved, insertions of MGE were identified in the intergenic regions of vanS/vanH and vanX/vanY. Furthermore, a variety of MGE insertions mediated integration of the vanA operon, including IS1216 and IS256 (figure). CONCLUSION: Accessory genes, including AMR genes, comprise a significant proportion of the enterococcal pan-genome, indicating major genetic plasticity within these organisms. Acquired resistance genes seem to have a high degree of recombination and play a substantial role in the expansion of the genomic repertoire in clinical isolates. [Image: see text] DISCLOSURES: Samuel L. Aitken, PharmD, Melinta Therapeutics: Grant/Research Support, Research Grant; Merck, Sharpe, and Dohme: Advisory Board; Shionogi: Advisory Board.
format Online
Article
Text
id pubmed-6811187
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68111872019-10-29 622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS) Simar, Shelby Hanson, Blake Contreras, German Reyes, Katherine Sahasrabhojane, Pranoti V Misikir, Helina Liu, Catherine Doi, Yohei Barberis, Fernanda Abbo, Lilian Dinh, An Q Spencer, Maria Zervos, Marcus Aitken, Samuel L Aitken, Samuel L van Duin, David Shelburne, Samuel A Shelburne, Samuel A Tran, Truc T Munita, Jose M Arias, Cesar A de los Angeles Spencer, Maria Open Forum Infect Dis Abstracts BACKGROUND: Vancomycin-resistant enterococci (VRE) are a major cause of nosocomial bloodstream infections. Enterococci exhibit remarkable genomic plasticity and can recombine through the acquisition of genetic material via mobile genetic elements (MGEs), including resistance genes. The accessory genome plays a major role in the evolution of enterococci within the human host. Thus, dissecting the entire genome (pan-genome) is of paramount importance to characterize the population structure of enterococci causing disease. METHODS: VENOUS is an ongoing prospective, observational study of adults with enterococcal bacteremia. From September 2016 to March 2018, E. faecalis (Efs) and E. faecium (Efm) were collected in 14 hospitals of a single hospital system and a major cancer center in Houston, TX, and a general hospital in Detroit, MI. Short- and long-read genomic sequencing were performed with Illumina MiSeq and Oxford Nanopore Technologies GridION X5, respectively. A proprietary bioinformatics pipeline was utilized for genome assembly and further analyses. RESULTS: 156 Efs and 98 Efm isolates from single patients were analyzed. The average proportion of core genes in each genome was 64.6% (53.0–74.1) and 49.1% (45.2–51.0) for Efs and Efm, respectively. The vanA gene cluster was identified in 5.1% (8/157) of Efs and 57.1% (56/98) of Efm. The plasmid-encoded aac(6′)-Ie-aph(2″)-Ia gene conferring high-level resistance to aminoglycosides was found in 37.6% (59/157) Efs, seven of which also possessed vanA. Long-read sequencing of vanA-harboring plasmids from a subset of VRE revealed that the vanA cluster was carried in plasmids ranging from 31.7 to 132.3 kb. Although the vanA operon was fairly conserved, insertions of MGE were identified in the intergenic regions of vanS/vanH and vanX/vanY. Furthermore, a variety of MGE insertions mediated integration of the vanA operon, including IS1216 and IS256 (figure). CONCLUSION: Accessory genes, including AMR genes, comprise a significant proportion of the enterococcal pan-genome, indicating major genetic plasticity within these organisms. Acquired resistance genes seem to have a high degree of recombination and play a substantial role in the expansion of the genomic repertoire in clinical isolates. [Image: see text] DISCLOSURES: Samuel L. Aitken, PharmD, Melinta Therapeutics: Grant/Research Support, Research Grant; Merck, Sharpe, and Dohme: Advisory Board; Shionogi: Advisory Board. Oxford University Press 2019-10-23 /pmc/articles/PMC6811187/ http://dx.doi.org/10.1093/ofid/ofz360.690 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Simar, Shelby
Hanson, Blake
Contreras, German
Reyes, Katherine
Sahasrabhojane, Pranoti V
Misikir, Helina
Liu, Catherine
Doi, Yohei
Barberis, Fernanda
Abbo, Lilian
Dinh, An Q
Spencer, Maria
Zervos, Marcus
Aitken, Samuel L
Aitken, Samuel L
van Duin, David
Shelburne, Samuel A
Shelburne, Samuel A
Tran, Truc T
Munita, Jose M
Arias, Cesar A
de los Angeles Spencer, Maria
622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)
title 622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)
title_full 622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)
title_fullStr 622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)
title_full_unstemmed 622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)
title_short 622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)
title_sort 622. the accessory genome in enterococcal bacteremia: results from the vancomycin-resistant enterococcal bacteremia outcomes study (venous)
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811187/
http://dx.doi.org/10.1093/ofid/ofz360.690
work_keys_str_mv AT simarshelby 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT hansonblake 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT contrerasgerman 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT reyeskatherine 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT sahasrabhojanepranotiv 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT misikirhelina 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT liucatherine 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT doiyohei 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT barberisfernanda 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT abbolilian 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT dinhanq 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT spencermaria 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT zervosmarcus 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT aitkensamuell 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT aitkensamuell 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT vanduindavid 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT shelburnesamuela 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT shelburnesamuela 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT trantruct 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT munitajosem 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT ariascesara 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous
AT delosangelesspencermaria 622theaccessorygenomeinenterococcalbacteremiaresultsfromthevancomycinresistantenterococcalbacteremiaoutcomesstudyvenous